HELP

CybinB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

Current thesis

The bull case is that HELP is entering a concentrated catalyst window: company materials point to a Q4 2026 HLP003 Phase 3 readout, a second Phase 3 study under way, and a cash position supplemented by the June 2026 offering [#PR-EARNINGS-2026-06-29]. The packet also shows a median analyst target of $31, implying upside if clinical execution de-risks materially, though target coverage count is unavailable and peer validation is weak.

Posture

Constructive

Lead driver

Momentum

What changed

Momentum remains the lead driver in the composite, 7D delta +5.5.

What can break

Coverage is thin and recent news flow is sparse, increasing the chance that price discovery around catalysts remains volatile and sentiment-driven.

Momentum

Value

Sentiment

Setup hits (3d)

— · Net —

AI TargetsBase $6.00 · Bull $9.50 · Bear $3.25

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

As of 2026-07-09 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade B · Constructive

Confidence Medium · Net —

Target $36.29

Why

Momentum94 · Δ7d +5.5

Value57 · Δ7d -0.2

Sentiment30 · Δ7d -7.1

So what

Strength-led posture. Favor watchlist adds and disciplined entries.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Momentum · See technicals

Momentum

26% active weight

Current posture

7d trendImproving

Δ7d

+5.5

Δ21d

+79.1

Value

39% active weight

Current posture

7d trendFlat

Δ7d

-0.2

Δ21d

-0.0

Sentiment

34% active weight

Current posture

7d trendSoftening

Δ7d

-7.1

Δ21d

Why this grade

Composite grade B. Momentum 93.6 / Value 56.8 / Sentiment 29.8

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$1.52M

Beta

0.14

Shares Out

61.98M

P/E (TTM) · Derived

-0.0

P/S (TTM)

P/FCF (TTM) · Derived

-0.01

Rev YoY

EPS YoY

+166.3%

Gross Margin

Op Margin

Net Debt

-$93.81M

Current Ratio

13.78

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology